HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Prognostic value of the pre-operative serum albumin to globulin ratio in patients with non-metastatic prostate cancer undergoing radical prostatectomy.

AbstractPURPOSE:
To evaluate the potential predictive value of the preoperative serum albumin to globulin ratio (AGR) for oncological outcomes in patients treated with radical prostatectomy (RP) for clinically non-metastatic prostate cancer (PCa).
METHODS:
Pre-operative AGR was assessed in a multi-institutional cohort of 6041 patients treated with RP. Logistic regression analyses were performed to assess the association of the AGR with advanced disease. We performed Cox regression analyses to determine the relationship between AGR and biochemical recurrence (BCR).
RESULTS:
The optimal cut-off value was determined to be 1.31 according to receiver operating curve analysis. Compared to patients with a higher AGR, those with a lower preoperative AGR had worse BCR-free survival (P < 0.01) in the Kaplan-Meier analysis. Pre- and post-operative multivariable models that adjusted for the effects of established clinicopathologic features, confirmed its independent association with BCR [hazard ratio (HR) 1.52, 95% confidence interval (CI) 1.31-1.75, P < 0.01, HR 1.55, 95% CI 1.34-1.79, P < 0.01, respectively]. However, the addition of AGR to established prognostic models did not improve their discrimination.
CONCLUSION:
While AGR is significantly associated with BCR, in the present study, the clinical impact of AGR was not large enough to affect patient management. Longer follow-up is necessary to observe the true effect of AGR.
AuthorsAbdulmajeed Aydh, Keiichiro Mori, David D'Andrea, Reza Sari Motlagh, Mohammad Abufaraj, Benjamin Pradere, Hadi Mostafaei, Ekaterina Laukhtina, Fahad Quhal, Pierre I Karakiewicz, Stefano Luzzago, Alberto Briganti, Quoc-Dien Trinh, Mehdi Kardoust Parizi, Derya Tilki, Dmitry V Enikeev, Shahrokh F Shariat
JournalInternational journal of clinical oncology (Int J Clin Oncol) Vol. 26 Issue 9 Pg. 1729-1735 (Sep 2021) ISSN: 1437-7772 [Electronic] Japan
PMID34184136 (Publication Type: Journal Article)
Copyright© 2021. The Author(s).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: